TROY FATE: Open Payments
NPI 1174514269 · DELAWARE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,159 in 145 payments from 29 companies in 2025. Trend: 2023 $1,124 · 2024 $2,370 · 2025 $3,159
Food & beverage: $3,159
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $517 |
| PFIZER INC. | 21 | $472 |
| Novo Nordisk Inc | 13 | $298 |
| Abbott Laboratories | 6 | $250 |
| AstraZeneca Pharmaceuticals LP | 14 | $210 |
| Kowa Pharmaceuticals America, Inc. | 7 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $151 |
| Axsome Therapeutics, Inc. | 5 | $138 |
| Exact Sciences Corporation | 4 | $135 |
| Phathom Pharmaceuticals, Inc. | 5 | $119 |
Products named: NURTEC ODT, FREESTYLE LIBRE 3, UBRELVY, Ozempic, ZORYVE, VRAYLAR, CAPLYTA, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
